Clinical Trials Directory

Trials / Unknown

UnknownNCT05503628

A Measurement Study of TIS-modNV and AccuGait Force Platform in People With MS

The Validity and Reliability of the Trunk Impairment Scale-modNV and the AMTI AccuGait Optimized Force Platform Across Mild and Moderate Disability Levels in the MS Population

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Nordlandssykehuset HF · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current project will fill a knowledge gap in the follow-up of people with Multiple Sclerosis (MS) with mild and moderate disability levels, with the purpose to assess the adequacy of measurement tools for trunk control and balance, functions that are pre-requisites for optimal performance in everyday physical activities.

Detailed description

Trunk control and balance, necessary for daily activities, are frequently impaired in people with MS. Adequate measurement tools for clinical- and research purposes are thus warranted. In this study two measurement tools will be explored: 1. The Trunk Impairment scale - modified Norwegian version (TIS-modNV), which has demonstrated high validity and reliability in individuals with stoke (Gjelsvik et al., 2012), however its properties has not yet been assessed in people with MS. Concurrent validity with a balance scale, the Mini-Balance Evaluation Systems Test (Mini-BESTest), will be assessed as well as its inter- and intra-rater reliability. 2. The AMTI Accugait Optimized™ multi-axis force platform (AMTI, Inc., Newton, MA) will be examined as there is a lack of studies measuring its properties within the MS population. A validity assessment of this tool will be included in this measurement study. This study is two-parted, each with a separate aim: Aim part 1: To determine the validity and reliability of the TIS-modNV across mild and moderate disability levels in the MS population. Aim part 2: To determine the concurrent validity of the AMTI AccuGait OptimizedTM force plate system compared to the Mini-BESTest across mild and moderate disability levels in the MS population.

Conditions

Timeline

Start date
2022-08-15
Primary completion
2023-01-01
Completion
2023-01-01
First posted
2022-08-16
Last updated
2022-08-19

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05503628. Inclusion in this directory is not an endorsement.